Pulsenmore Ltd. (TLV:PULS)
Israel · Delayed Price · Currency is ILS · Price in ILA 469.80
-0.40 (-0.09%)
Oct 5, 2025, 3:49 PM IDT
Pulsenmore Market Cap
Pulsenmore has a market cap or net worth of 243.56 million as of October 7, 2025. Its market cap has increased by 15.79% in one year.
Market Cap
243.56M
Enterprise Value
158.63M
Revenue
9.31M
Ranking
n/a
PE Ratio
n/a
Stock Price
469.80
Market Cap Chart
Since June 15, 2021, Pulsenmore's market cap has decreased from 795.01M to 243.56M, a decrease of -69.36%. That is a compound annual growth rate of -24.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 5, 2025 | 243.56M | -3.20% |
| Dec 31, 2024 | 251.62M | -29.08% |
| Dec 31, 2023 | 354.81M | -4.28% |
| Dec 29, 2022 | 370.68M | -42.16% |
| Dec 30, 2021 | 640.93M | -19.38% |
| Jun 15, 2021 | 795.01M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 75.93B |
| Danel (Adir Yeoshua) | 3.10B |
| Kamada | 1.31B |
| Bait Bakfar | 974.87M |
| BrainsWay | 961.20M |
| SofWave Medical | 943.38M |
| Ilex Medical | 714.47M |
| Novolog (Pharm-Up 1966) | 661.07M |